Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Barclays Maintains Underweight on Phibro Animal Health, Lowers Price Target to $17

Barclays Maintains Underweight on Phibro Animal Health, Lowers Price Target to $17

Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and lowers the price target from $22 to $17.

September 16, 2022

1 minute read

Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and lowers the price target from $22 to $17.

iPhone Users, Beware: Another Pegasus-Like Spyware Has Been Sold To Governments

April 12, 6:52 AM

RememberÂ Pegasus, the softwareÂ allegedly used by the government and other agencies to spy on people’s cell phones? It appears…

December 15, 6:38 AM

Wedbush analyst Taz Koujalgi initiates coverage on 8x8 (NASDAQ:EGHT) with a Neutral rating and announces Price Target of $7.

November 16, 9:09 AM

Argus Research analyst Kevin Heal downgrades Rocket Companies (NYSE:RKT) from Hold to Sell.

February 16, 1:10 PM

The biggest squeeze in the cocoa market in more than a decade has pushed prices of the commodity to record highs.